Circulating tumor DNA identifies EGFR coamplification as a mechanism of resistance to crizotinib in a patient with advanced MET-amplified lung adenocarcinoma
I Dagogo-Jack, D Fabrizio, J Lennerz, AB Schrock… - Journal of Thoracic …, 2017 - jto.org
Circulating Tumor DNA Identifies EGFR Coamplification as a Mechanism of Resistance to
Crizotinib in a Patient with Advanced MET-Amplified Lung Adenocarcinoma - Journal of Thoracic
Oncology Skip to Main Content Advertisement Journal of Thoracic Oncology IASLC Log in at
IASLC Submit Log in Register Log in Log in at IASLC Submit Log in Subscribe Claim Skip
menu Articles Cover Image - Journal of Thoracic Oncology, Volume 18, Issue 7 Latest Articles
in Press Current Issue Past Issues Editor's Choice Popular Articles State of the Art: Concise …
Crizotinib in a Patient with Advanced MET-Amplified Lung Adenocarcinoma - Journal of Thoracic
Oncology Skip to Main Content Advertisement Journal of Thoracic Oncology IASLC Log in at
IASLC Submit Log in Register Log in Log in at IASLC Submit Log in Subscribe Claim Skip
menu Articles Cover Image - Journal of Thoracic Oncology, Volume 18, Issue 7 Latest Articles
in Press Current Issue Past Issues Editor's Choice Popular Articles State of the Art: Concise …